Related Experiment Video

Updated: Aug 30, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

Serum MUC-1 as a marker of disease status in multiple myeloma patients receiving thalidomide

Linda Mileshkin, H M Prince, J F Seymour

    British Journal of Haematology
    |November 18, 2003
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Concept Videos